Cargando…
Serum Soluble Vascular Endothelial Growth Factor Receptor 1 as a Potential Biomarker of Hepatopulmonary Syndrome
BACKGROUND AND AIMS: The results of basic research implicate the vascular endothelial growth factor (VEGF) family as a potential target of hepatopulmonary syndrome (HPS). However, the negative results of anti-angiogenetic therapy in clinical studies have highlighted the need for markers for HPS. The...
Autores principales: | Li, Yu-Jie, Wu, Xian-Feng, Wang, Dan-Dan, Li, Peng, Liang, Hao, Hu, Xiao-Yan, Gan, Jia-Qi, Sun, Yi-Zhu, Li, Jun-Hong, Li, Jun, Shu, Xin, Song, Ai-Lin, Yang, Chun-Yong, Yang, Zhi-Yong, Yu, Wei-Feng, Yang, Li-Qun, Wang, Xiao-Bo, Belguise, Karine, Xia, Zheng-Yuan, Yi, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412700/ https://www.ncbi.nlm.nih.gov/pubmed/37577229 http://dx.doi.org/10.14218/JCTH.2022.00421 |
Ejemplares similares
-
MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia
por: Chen, Yang, et al.
Publicado: (2019) -
Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndrome
por: Chen, Lin, et al.
Publicado: (2019) -
Loss of cell polarity regulated by PTEN/Cdc42 enrolled in the process of Hepatopulmonary Syndrome
por: Gao, Jing, et al.
Publicado: (2019) -
Endothelial glycocalyx in hepatopulmonary syndrome: An indispensable player mediating vascular changes
por: Li, Liang, et al.
Publicado: (2022) -
Inhibition of autophagy ameliorates pulmonary microvascular dilation and PMVECs excessive proliferation in rat experimental hepatopulmonary syndrome
por: Xu, Duo, et al.
Publicado: (2016)